trending Market Intelligence /marketintelligence/en/news-insights/trending/aLPPFcfFagPPf0sCXIxdfg2 content esgSubNav
In This List

InMed Pharmaceuticals names CFO

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


InMed Pharmaceuticals names CFO

InMed Pharmaceuticals Inc. appointed Jeff Charpentier as CFO and corporate secretary.

Charpentier replaces outgoing CFO Terese Gieselman. He has previously served as CFO for Lifebank Corp., Inex Pharmaceuticals Corp. and Chromos Molecular Systems Inc.